Stifel Initiates Coverage of Immunome with Hold Rating
Published . Updated .
Fintel reports that on October 1, 2026, Stifel initiated coverage of Immunome (NASDAQCM:IMNM) with a Hold recommendation.On the rating action date of October 1, 2026, the latest close for the stock was $20.89, while the pre-action close on September 30, 2026, was $21.51. The pric
Directly affected
- IMNM Immunome
Named in this report.
Indirectly affected
- UPGD INVESCO BLOOMBERG ANALYST RATING ETF
GA selected UPGD as a RELATED security because its canonical security name directly matches this event's themes: rating. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Fintel reports that on October 1, 2026, Stifel initiated coverage of Immunome (NASDAQCM:IMNM) with a Hold recommendation.On the rating action date of October 1, 2026, the latest close for the stock was $20.89, while the pre-action close on…
Source: Nasdaq Markets
Price since this story was published: Immunome (IMNM)
Since the first closing price after “Stifel Initiates Coverage of Immunome with Hold Rating,” Immunome (IMNM) is -19.69%. The S&P 500 fund (SPY) is -0.40% over the same days, a -19.29% difference versus the market.
Who is named in “Stifel Initiates Coverage of Immunome with Hold Rating”
Companies mentioned with this story
- IMNM Immunome
In “Stifel Initiates Coverage of Immunome with Hold Rating,” Immunome (IMNM) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names IMMUNOME INC in the headline; GA resolved that company to IMNM
- UPGD Invesco Bloomberg Analyst Rating Etf
For “Stifel Initiates Coverage of Immunome with Hold Rating,” Invesco Bloomberg Analyst Rating Etf (UPGD) is linked, with no stored direction, medium confidence. Reason on file: GA selected UPGD as a RELATED security because its canonical security name directly matches this event's themes: rating. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “Stifel Initiates Coverage of Immunome with Hold Rating” reaches Immunome (IMNM)
Immunome (IMNM) is the company in “Stifel Initiates Coverage of Immunome with Hold Rating,” the 1 Oct 2026 this story story.
The link for Immunome (IMNM) is this: The reported development directly names IMMUNOME INC in the headline; GA resolved that company to IMNM
A second company, Invesco Bloomberg Analyst Rating Etf (UPGD), is listed for a different reason: GA selected UPGD as a RELATED security because its canonical security name directly matches this event's themes: rating. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Immunome (IMNM), and the dates in the story
IMNM traded between 16.42 and 21.47 across 13 sessions. The latest close on file is 16.79. UPGD traded between 80.14 and 82.00 across 17 sessions. The latest close on file is 82.00.
How strong the case is around Immunome (IMNM)
21 out of 100
“Stifel Initiates Coverage of Immunome with Hold Rating” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.